These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 1783249
1. [Impaired fibrinolytic response to the venous occlusion test in patients with cryptogenic colitis]. Gris JC, Schved JF, Raffanel C, Dubois A, Ribard D, Balmes JL. Gastroenterol Clin Biol; 1991; 15(12):933-8. PubMed ID: 1783249 [Abstract] [Full Text] [Related]
2. Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Gris JC, Schved JF, Raffanel C, Dubois A, Aguilar-Martinez P, Arnaud A, Sanchez N, Sarlat C, Balmès JL. Thromb Haemost; 1990 Jun 28; 63(3):472-5. PubMed ID: 2119529 [Abstract] [Full Text] [Related]
3. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EK. Thromb Haemost; 1992 Apr 02; 67(4):397-401. PubMed ID: 1631786 [Abstract] [Full Text] [Related]
4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A, Ruusuvaara L. Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043 [Abstract] [Full Text] [Related]
5. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease. Sultan Y, Loyer F, Venot A. Nouv Rev Fr Hematol (1978); 1992 Dec 22; 34(1):55-60. PubMed ID: 1523100 [Abstract] [Full Text] [Related]
6. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium. Stegnar M, Zore A, Novak-Antolic Z, Vovk N, Kruithof EK. Thromb Haemost; 1993 Sep 01; 70(3):486-90. PubMed ID: 8259554 [Abstract] [Full Text] [Related]
7. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F. Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812 [Abstract] [Full Text] [Related]
12. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets. Matsumoto M, Uchiyama T, Kobayashi N, Maekawa T. Nihon Ketsueki Gakkai Zasshi; 1989 Sep 08; 52(6):1105-14. PubMed ID: 2588960 [Abstract] [Full Text] [Related]
13. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF. J Lab Clin Med; 1993 Nov 08; 122(5):606-15. PubMed ID: 8228580 [Abstract] [Full Text] [Related]
20. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. Wieczorek I, Ludlam CA, MacGregor IR. Blood Coagul Fibrinolysis; 1994 Jun 08; 5(3):329-34. PubMed ID: 8075304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]